Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
This study included 36 pediatric patients (age, 1-14 years; median, 7.3) newly diagnosed with T-lineage ALL and being treated at Hematology Center of Beijing Children’s Hospital, Capital Medical University, between February 2016 and July 2019. The Chinese Children’s Leukemia Group (CCLG)–ALL 2008 protocol17 was used in 22 patients and the CCLG-ALL 2018 protocol was used in 14 patients. A total of 4 samples were obtained from children with immune thrombocytopenic purpura as negative controls.
Copyright and License information: ©2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
